Hashida Nao, Suzuki Motoyuki, Hosokawa Kiyohito, Takenaka Yukinori, Fukusumi Takahito, Takemoto Norihiko, Tanaka Hidenori, Kitamura Koji, Eguchi Hirotaka, Umatani Masanori, Kitayama Itsuki, Nozawa Masayuki, Kato Chieri, Okajima Eri, Inohara Hidenori
Swallowing Center, Osaka University Hospital, 2-15, Yamadaoka, Suita City, Osaka, 565-0871, Japan.
Department of Otorhinolaryngology-Head and Neck Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita City, Osaka, 565-0871, Japan.
Support Care Cancer. 2025 Jan 14;33(2):97. doi: 10.1007/s00520-024-09134-6.
Chemoradiotherapy (CRT) for head and neck cancer (HNC) often causes dysphagia. The risk of dysphagia increases during CRT tends to become more severe after finishing CRT, and persists for a few weeks thereafter. Thus, understanding the changes in swallowing physiology during and immediately after CRT is essential. This study aimed to clarify the changes in the swallowing response during and early after CRT and identify associated factors.
This retrospective study enrolled 107 patients with HNC who underwent CRT. We measured pharyngeal delay time (PDT) and laryngeal elevation delay time (LEDT) as indicators of the timing of the swallowing response at three time points: at CRT initiation (baseline), at 40-Gy irradiation during CRT (mid-CRT) and within 2 weeks following the completion of CRT (early post-CRT) as primary outcomes; and subgroup analyses based on clinical parameters, such as tumor sites, T stage, N stage, and opioid use at 40-Gy irradiation as secondary outcomes.
Both PDT and LEDT were significantly prolonged between baseline and mid-CRT (PDT: p = 0.003, LEDT: p = 0.002) and between baseline and early post-CRT (PDT, p = 0.001; LEDT, p < 0.001). N2c/N3 and opioid use at 40-Gy irradiation showed prolonged PDT and LEDT at mid-CRT and early post-CRT.
PDT and LEDT were prolonged at mid-CRT irradiation and further extended at early post-CRT. Additionally, N2c/N3 involvement, which typically necessitates bilateral neck irradiation fields and opioid use at mid-CRT, may constitute as risk factors for a delayed swallowing response.
头颈部癌(HNC)的放化疗(CRT)常导致吞咽困难。吞咽困难的风险在CRT期间增加,在CRT结束后往往会变得更严重,并在此后持续数周。因此,了解CRT期间及刚结束后吞咽生理的变化至关重要。本研究旨在阐明CRT期间及早期吞咽反应的变化并确定相关因素。
这项回顾性研究纳入了107例行CRT的HNC患者。我们测量了咽延迟时间(PDT)和喉提升延迟时间(LEDT),作为吞咽反应时间的指标,在三个时间点进行测量:CRT开始时(基线)、CRT期间40 Gy照射时(CRT中期)以及CRT完成后2周内(CRT早期)作为主要结局;并基于临床参数进行亚组分析,如肿瘤部位、T分期、N分期以及40 Gy照射时使用阿片类药物作为次要结局。
PDT和LEDT在基线和CRT中期之间均显著延长(PDT:p = 0.003,LEDT:p = 0.002),在基线和CRT早期之间也显著延长(PDT,p = 0.001;LEDT,p < 0.001)。N2c/N3以及40 Gy照射时使用阿片类药物在CRT中期和CRT早期显示出PDT和LEDT延长。
PDT和LEDT在CRT中期照射时延长,并在CRT早期进一步延长。此外,N2c/N3受累,通常需要双侧颈部照射野且在CRT中期使用阿片类药物,可能构成吞咽反应延迟的危险因素。